ALTESA BIOSCIENCES, INC.

Profile

Company Names

ALTESA BIOSCIENCES, INC.

Addresses

1930 HARVARD AVENUE, COLLEGE PARK, GA 30337

1930 HARVARD STREET, COLLEGE PARK, GA 30337

Phone Numbers

703-795-4274

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2020

State Incorporated:

DELAWARE

Total Amount Raised:

$109,999,986.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2026-02-13 
$74,999,986.00 
$74,999,986.00 
$0.00 
Equity 
1
2022-12-22 
$35,000,000.00 
$35,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOHN 
 
CLERICI 
EXECUTIVE OFFICER, PROMOTER
ALTESA BIOSCIENCES, INC.
ANDREW 
 
DRECHSLER 
EXECUTIVE OFFICER
ALTESA BIOSCIENCES, INC.
JON 
 
EDWARDS 
DIRECTOR
GOLDWATER BANCORP, INC.   |  ALTESA BIOSCIENCES, INC.
BRETT 
 
GIROIR 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
REVELAR BIOTHERAPEUTICS, INC.   |  ALTESA BIOSCIENCES, INC.   |  ONCONANO MEDICINE, INC.
ITTAI 
 
HAREL 
DIRECTOR
INOTEK PHARMACEUTICALS CORP   |  VALERITAS INC   |  VERTOS MEDICAL INC   |  TSCAN THERAPEUTICS, INC.   |  IMMUNEID, INC.   |  ALTESA BIOSCIENCES, INC.   |  HOMETHRIVE, INC.
SETH 
 
RUDNICK 
DIRECTOR
VAXINNATE CORP   |  LIQUIDIA TECHNOLOGIES INC   |  ENVISIA THERAPEUTICS INC.   |  G1 THERAPEUTICS, INC.   |  LQ3 PHARMACEUTICALS, INC.   |  MERYX INC.   |  ENVISIA THERAPEUTICS, INC.   |  ALTESA BIOSCIENCES, INC.
MONCEF 
 
SLAOUI 
DIRECTOR
SUTROVAX, INC.   |  ARTIZAN BIOSCIENCES, INC.   |  ALTESA BIOSCIENCES, INC.   |  ZEPHYR AI, INC.   |  CUREVO, INC.
NICHOLAS 
 
WILLIAMS 
DIRECTOR
BLUEBAY MACRO FUND LP   |  BLUEBAY MACRO FUND LTD.   |  BLUEBAY EMERGING MARKET ENHANCED OPPORTUNITY FUND LP   |  BLUEBAY EMERGING MARKET ENHANCED OPPORTUNITY FUND LTD   |  BLUEBAY EMERGING MARKET CORPORATE ALPHA FUND LTD.   |  BLUEBAY CREDIT ALPHA LONG SHORT FUND LTD.   |  BLUEBAY INVESTMENT GRADE ABSOLUTE RETURN BOND SP OF THE BLUEBAY GLOBAL FUNDS SPC   |  BLUEBAY EMERGING MARKET SELECT BOND SP OF THE BLUEBAY GLOBAL FUNDS SPC   |  BLUEBAY CREDIT ALPHA LONG SHORT (MASTER) FUND LTD   |  BLUEBAY EMERGING MARKET CORPORATE ALPHA (MASTER) FUND LTD   |  BLUEBAY EMERGING MARKET FIXED INCOME OPPORTUNITY (MASTER) FUND LTD   |  BLUEBAY MACRO (MASTER) FUND LTD   |  BLUEBAY EVENT DRIVEN CREDIT (MASTER) PARTNERSHIP LTD   |  BLUEBAY EVENT DRIVEN CREDIT FUND LTD   |  BLUEBAY TOTAL RETURN CREDIT SP OF THE BLUEBAY GLOBAL FUNDS SPC   |  GLOBAL FUNDS SPC - TOTAL RETURN CREDIT SP   |  GLOBAL SOVEREIGN OPPORTUNITIES FUND LP   |  GLOBAL FUNDS SPC - EMERGING MARKET BLENDED BOND SP   |  BLUEBAY GLOBAL STRUCTURED CREDIT OPPORTUNITIES FUND LP   |  NOVELLA, INC.   |  BLUEBAY GLOBAL SECURITIZED CREDIT OPPORTUNITIES FUND LP   |  ALTESA BIOSCIENCES, INC.   |  BLUEBAY GLOBAL CREDIT ALPHA LONG SHORT FUND LTD   |  BLUEBAY EMERGING MARKET CREDIT ALPHA FUND LTD.   |  GLOBAL FUNDS SPC - EMERGING MARKET SELECT BOND SP   |  BLUEBAY EVENT DRIVEN CREDIT FUND LTD.   |  BLUEBAY GLOBAL CREDIT ALPHA LONG SHORT FUND LP   |  BLUEBAY GLOBAL SOVEREIGN OPPORTUNITIES FUND LP   |  GLOBAL FUNDS SPC - BLUEBAY EMERGING MARKET CREDIT ALPHA SP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-02-23
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2026-02-13 
2023-07-07
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-22 
2023-01-05
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-12-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#